Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid β-cell tumors

Endocrinology

Volumn 143, Issue 10, 2002, Pages 4018-4030

  Galbiati, Francesca ^a   Polastri, Luca ^a   Gregori, Silvia ^a   Freschi, Massimo ^a   Casorati, Mara ^b   Cavallaro, U G O ^c   Fiorina, Paolo ^d   Bertuzzi, Federico ^a   Zerbi, Alessandro ^a   Pozza, Guido ^a   Adorini, Luciano ^a   Folli, Franco ^a   Christofori, Gerhard ^a   Davalli, Alberto M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c ROCHE MILANO RICERCHE   (Italy)

^d RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; STAUROSPORINE;

APOPTOSIS; ARTICLE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPERPARATHYROIDISM; HYPOGLYCEMIA; IMMUNE RESPONSE; INSULIN RELEASE; INSULINOMA; PANCREAS ISLET BETA CELL; PANCREAS TUMOR; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SOLID TUMOR; SURVIVAL RATE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCITRIOL; CELL DIVISION; CELL SURVIVAL; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; INSULIN; INSULIN ANTAGONISTS; INSULINOMA; ISLETS OF LANGERHANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE C;

EID: 0036773343     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220200     Document Type: Article

References (64)

1. Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257
2. Jones G, Strugnell SA, DeLuca HF 1998 Current understanding of the molecular actions of vitamin D. Physiol. Rev 78:1193-1231
3. Otoshi T, Iwata H, Kitano M, Nishizawa Y, Morii H, Yano Y, Otani S, Fukushima S 1995 Inhibition of intestinal tumor development in rat multiorgan carcinogenesis and aberrant crypt foci in rat colon carcinogenesis by 22-oxa-calcitriol, a synthetic analogue of aα, 25-dihydroxyvitamin D3. Carcinogenesis 16:2091-2097
4. Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T, Nikaido T, Furihata K 1996 Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology 110:1605-1613
5. Baudet C, Chevalier G, Chassevent A, Canova C, Filmon R, Larra F, Brachet P, Wion D 1996 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. J Neurosci Res 46:540-550
6. Danielsson C, Fehsel K, Polly P, Carlberg C 1998 Differential apoptotic response of human melanoma cells to 1α, 25-dihydroxyvitamin D3 and its analogues. Cell Death Differ 5:946-952
7. VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J 1998 Apoptotic regression of MCF-7 xenografts in nude mice treated with vitamin D3 analog, EB1089. Endocrinology 139:2102-2110
8. Feldman D, Zhao XY, Krishnan AV 2000 Vitamin D and prostate cancer. Endocrinology 141:5-9
9. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS 1999 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21 (waf1/Cip1) in vitro and in vivo. Cancer Res 59:2644-2649
10. Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL 1999 A phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res 5:1339-1345
11. Pavelic K, Hrascan R, Kapitanovic S, Karapandza N, Vranes Z, Belicza M, Kruslin B, Cabrijan T 1995 Multiple genetic alterations in malignant metastatic insulinomas. J Pathol 177:395-400
12. Ruszniewski P, Malka D 2000 Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 62(Suppl 1):79-83
13. Schott M, Scherbaum WA, Feldkamp J 2000 Drug therapy of endocrine neoplasms. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids and other tumors. Med Klin 95:81-84
14. Arnold R, Simon B, Wied M 2000 Treatment of neuroendocrine GEP tumors with somatostatin analogues: A review. Digestion 62(Suppl 1):84-91
15. Ishida H, Norman AW 1988 Demonstration of high affinity receptor for 1,25-dihydroxyvitamin D3 in rat pancreas. Mol Cell Endocrinol 60:109-117
16. Johnson JA, Grande JP, Roche PC, Kumar R 1994 Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28K in human and rat pancreas. Am J Physiol 267:E356-E360
17. Norman AW, Frankel BJ, Heldt AM, Grodsky GM 1980 Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823-825
18. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, DeLuca HF 1983 Cellular mechanisms of insulin release: The effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113:1511-1518
19. Gedik O, Akalin S 1986 Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29:142-145
20. Mak RH 1992 Intravenous 1, 25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 41:1049-1054
21. Chertow BS, Sivitz WI, Baranetsky Cordle MB, DeLuca HF 1986 Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats. Diabetes 35:771-775
22. Lee S, Clark SA, Gill RK, Christakos S 1994 1, 25-dihydroxyvitamin D3 and pancreatic β-cell function: Vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134:1602-1610
23. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R 1994 Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diabetologia 37:552-558
24. 3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367-1374
25. Mcdermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, Snehalatha C, Hitman GA 1997 Allelic variations in the vitamin D receptor influences susceptibility to IDDM in indian Asians. Diabetologia 40:971-975
26. Hitman GA, Mannan N, McDermott MF, Aganna E, Ogunkolade BW, Hales CN, Boucher BJ 1998 Vitamin D receptor polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 47:688-690
27. Speer G, Cseh K, Winker G, Vargha P, Braun E, Takacs I, Lakato P 2001 Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 144:385-389
28. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S 1988 Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85:9037-9041
29. Hanahan D 1985 Heritable formation of pancreatic beta-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122
30. Teitelman G, Alpert S, Hanahan D 1988 Proliferation, senescence, and neoplastic progression of β cells in hyperplasic pancreatic islets. Cell 52:97-105
31. Folkman J, Watson K, Ingber D, Hanahan D 1989 Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61
32. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G 1998 A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190-193
33. Perl AK, Dahl U, Wilgenbus P, Cremer H, Semb H, Chrisofori G 1999 Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells. Nat Med 5:286-291
34. Solcia E, Rindi G, Palotti D, La Rosa S, Capella C, Fiocca R 1999 Clinicopathological profile as a basis for classification on the endocrine tumors of the gastroenteropancreatic tract. Ann Oncol 10:S9-S15
35. Socci C, Falqui L, Davalli AM, Ricordi C, Braghi S, Bertuzzi F, Maffi P, Secchi A, Gavazzi F, Freschi M, Magistretti P, Socci S, Vignali A, Di Carlo V, Pozza G 1991 Fresh human islet transplantation to replace pancreatic endocrine function in type I diabetic patients. Report of six cases. Acta Diabetol 28:151-157
36. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
37. Davalli AM, Galbiati F, Bertuzzi F, Polastri L, Pontiroli AE, Perego L, Freschi M, Pozza G, Folli F, Meoni C 2000 Insulin-secreting pituitary GH3 cells: A potential β-cell surrogate for diabetes cell therapy. Cell Transplant 8:841-851
38. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pittis WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskas JM 1998 Identification of a novel inhibitor of mitogen-activated protein kinase. J Biol Chem 273:18623-18632
39. Davalli AM, Ogawa Y, Scaglia L, Wu YJ, Hollister J, Bonner-Weir S, Weir GC 1995 Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44:104-111
40. Song X, Bishop JE, Okamura WH, Norman AW 1998 Stimulation of phosphorylation of mitogeh-activated protein kinase by 1α,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: A structure-function study. Endocrinology 139:457-465
41. Ryan KM, Ernst MK, Rice NR, Vousden KH 2000 Role of NF-κB in p-53-mediated programmed cell death. Nature 404:892-897
42. Verstuyf A, Segaert S, Verlinden L, Casteels K, Bouillon R, Mathieu C 1998 Recent developments in the use of vitamin D analogues. Curr Opin Nephrol Hypertens 7:397-403
43. Atley LM, Lefroy N, Wark JD 1995 1, 25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells. J Endocrinol 147:397-404
44. Zhuang SH, Burnstein KL 1998 Antiproliferative effect of 1alpha, 25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP revolves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 139:1197-1207
45. Scaglione-Sewell BA, Bissonnette M, Skarosi S, Abraham C, Brasitus TA 2000 A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting Cdk2 and Cdk6: Roles of cyclin E, p21waf1, and p27kip1. Endocrinology 141:3931-3939
46. Hausmann G, O'Reilly LA, van Driel R, Beaumont JG, Strasser A, Adams JM, Huang DC 2000 Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bclx-(L). J Cell Biol 149:623-634
47. Chiou SK, Rao L, White E 1994 Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14:2556-2563 0
48. Blutt SE, McDonnel TJ, Polek TC, Weigel NL 2000 Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 141:10-17
49. Hmama Z, Nandan D, Sly L, Knutson KL, Henera-Velit P, Reiner NE 1999 1α,25-Dihydroxyvitamin D3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med 190:1583-1594
50. Nemere Z, Schwartz Z, Pedrozo H, Sylvia VL, Dean DD, Boyan BD 1998 Identification of a membrane receptor for 1α,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res 13:1353-1359
51. Baran DT 1994 Nongenomic actions of the steroid hormone 1 α,25-dihydroxyvitamin D3. J Cell Biochem 56:303-306
52. Marcinkowska E, Wiedlocha A, Radzikowski C 1997 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem Biophys Res Comun 24:419-426
53. Xu G, Marshall CA, Lin TA, Kwon G, Munivenkatappa RB, Hill JR, Lawrence JC, McDaniel ML 1998 Insulin mediates glucose-stimulated phosphorylation of PHAS-I by pancreatic β cells. An insulin-receptor mechanism for autoregulation of protein synthesis by translation. J Biol Chem 273:4485-4491
54. Kahn BB 1998 Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell 92:593-596
55. Rothenberg PL, Willison LD, Simon J, Wolf BA 1995 Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells. Diabetes 44:802-809
56. Harbeck MC, Louie DC, Howland J, Wolf BA, Rothenberg PL 1996 Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet β-cells. Diabetes 45:711-717
57. Xu GG, Rothenberg PL 1998 Insulin receptor signaling in the β-cell influences insulin gene expression and insulin content evidence for autocrine β-cell regulation. Diabetes 47:1243-1252
58. Leibiger IB, Leibiger B, Moede, T, Berggren PO 1998 Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1:933-938
59. DeVente JE, Carey JO, Bryant WO, Pettit GJ, Ways DK 1996 Transcriptional regulation of insulin receptor substrate 1 by protein kinase C. J Biol Chem 271:32276-32280
60. 2+ homeostasis and insulin secretion. J Biol Chem 274:18067-18074
61. 972-Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β cells. J Clin Invest 104:357-364
62. Mantell DJ, Mawer EB, Bundred NJ, Canfield AE 1997 The effects of 1, 25-dihydroxyvitamin D3 on angiogenesis in vitro. In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D. Chemistry, Biology and Clinical Applications of the Steroid Hormone. Riverside, CA: University of California; 471-472
63. Schwartz GG, Lokeshwar BL, Selzer MG, Block NL, Binderup L 1997 1α, 25-(OH)2 vitamin D and EB1089 inhibit prostate cancer metastases in vivo. In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D. Chemistry, Biology and Clinical Applications of the Steroid Hormone. Riverside, CA: University of California; 489-490
64. Guyton KZ, Kensler TW, Posner GH 2001 Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol 41:421-442